Clinica Quirón Salud, Córdoba Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2019
NCT04683263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinica Quirón Salud, Córdoba | Quironsalud

Active Ingredients

Drugs in Phase 3 Trials (1)

house dust mite allergen (1 trial)

Drugs in Phase 2 Trials (1)

plitidepsin (1 trial)

Drugs in Other Trials (4)

arnica montana (1 trial)

calendula officinalis (1 trial)

hypericum perforatum (1 trial)

menthol (Salonpas) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6